Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07622927
Recruiting
FOCUS Bipolar: Families Opening Conversations for Understanding Signs
Not applicable · United States · 1 site
Registry update: 3 Jun 2026
NCT07286058
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Phase 3 · Australia, Belgium, Bulgaria, China, Czechia, Germany, Estonia, Spain, France, Croatia, Hungary, Israel, Italy, Japan, Latvia, New Zealand, Poland, Puerto Rico, Portugal, Taiwan, United States · 163 sites
Registry update: 9 Sept 2026
NCT07600411
Recruiting
Binge Eating, Depression and Anxiety Outcomes After Sleeve Gastrectomy Versus Gastric Bypass: A Cohort Study
Not applicable · Egypt · 1 site
Registry update: 20 May 2026
NCT07479433
Recruiting
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
Not applicable · United States · 1 site
Registry update: 23 Mar 2026
NCT07529197
Recruiting
Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS
Not applicable · Germany · 1 site
Registry update: 14 Apr 2026
NCT07477457
Recruiting
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
Phase 2 · United States · 7 sites
Registry update: 17 Mar 2026
NCT07457918
Recruiting
Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)
Phase 3 · Japan, United States · 12 sites
Registry update: 22 Oct 2026
NCT07276360
Recruiting
Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda
Phase 2 · Uganda · 1 site
Registry update: 27 Mar 2026
NCT07472868
Recruiting
Neoadjuvant FOLFOXIRI and Chemoradiotherapy versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy, followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer
Phase 3 · Netherlands · 25 sites
Registry update: 24 Sept 2026
NCT07428707
Recruiting
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
Early phase 1 · United States · 1 site
Registry update: 22 Oct 2026
NCT07343869
Recruiting
Multicenter Prospective Cohort on Esophageal Endoscopic Submucosal Dissection
Not applicable · France · 7 sites
Registry update: 6 Nov 2026
NCT07772895
Recruiting
Pemefolacianine for IMI of Lung Cancer
Phase 1 · United States · 1 site
Registry update: 19 Aug 2026
NCT07560878
Recruiting
Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
Early phase 1 · United States · 1 site
Registry update: 13 May 2026
NCT07491497
Recruiting
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Phase 1/2 · Australia, Germany, Spain, France, United Kingdom, Italy, United States · 40 sites
Registry update: 5 Nov 2026
NCT07595224
Recruiting
Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
Not applicable · Thailand · 1 site
Registry update: 19 May 2026
NCT06684613
Recruiting
Integrating PrEP Decision Making Into Counseling in Sexual and Reproductive Health Clinics
Phase 2 · United States · 1 site
Registry update: 4 Sept 2026
NCT07481383
Recruiting
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
Phase 1 · United States · 2 sites
Registry update: 6 Jul 2026
NCT07458425
Recruiting
The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk
Not applicable · United States · 1 site
Registry update: 6 Apr 2026
NCT07421700
Recruiting
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Phase 1/2 · Australia, China, Spain, Japan, Puerto Rico, United States · 179 sites
Registry update: 8 Oct 2026
NCT07302230
Recruiting
Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial
Not applicable · United States · 1 site
Registry update: 6 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.